logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table DUP-0. Prevalence of drug use among prisoners: sources and bibliographic references

CountrySourceReference
Belgium1Van Malderen, S., Pauwels, L., Walthoff-Borm, C., Glibert, P., Todts, S. (2011). Druggebruik in Belgische gevangenissen. Monitoring van gezondheidsrisico’s 2010. (in preparation) Brussel: Federale Overheidsdienst Justitie: Bruxelles; .
2Todts S, Glibert P, Van Malderen S, Van Huyck C, Saliez V, Hogge M. Usage de drogues dans les prisons belges: Monitoring des risques sanitaires. Service Public Fédéral Justice: Bruxelles; 2009.
3Todts S, Hariga F, Pozza M, Leclercq D, Glibert P, Micalessi MI. Drug use in Belgian prisons: monitoring health risks 2006 Final Report, Modus Vivendi, Brussels; 2007.
4Hariga F, Todts S, Doulou M, Muys M. Toxicomanie en prison: monitoring des risques sanitaires: une enquête dans 10 prisons belges, SPF Justice Bruxelles; 2004. // Hariga F, Todts S, Doulou M, Muys M. e.a., Drug use in prisons : monitoring of health risks. A survey in 10 Belgian prisons: final report, Brussels, Modus Vivendi. 2004; 40 p.
5De Maere W, Hariga F, Bartholeyns F, Vandeverken M. Druggberuik in de gevangenisomgeving. Ontwikkeling van een epidemiologisch onderzoeksinstrusment. Onderzoek uitgevoerd in opdracht van DWTC/SSTC; 2000.
6Weilandt C. Rotily M, European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD; 1998.
7Todts S, Fonck K, Colebunders R, Vercauteren G, Driesen K, Uydebreouck M, Vranckx R, Van Mol F. Tuberculosis, HIV, Hepatitis B and risk behaviour in a Belgian prison, Arch Public Health. 1997; 55:87–98.
Bulgaria1National Drug Council. National Focal Point for Drugs and Drugs Addictions. Annual report on the state of drug related problems in Bulgaria 2012. Sofia; 2012.
2National Drug Council. National Focal Point for Drugs and Drugs Addictions. Annual report on the state of drug related problems in Bulgaria 2011. Sofia; 2011.
3National Drug Council. National Focal Point for Drugs and Drugs Addictions. Annual report on the state of drug related problems in Bulgaria 2010. Sofia; 2010. https://reitox.emcdda.europa.eu/attachements.cfm/att_121168_EN_2010%20NATIONAL%20REPORT%20BG_en.doc Accessed: 2011-01-04.
4National Drug Council. National Focal Point for Drugs and Drugs Addictions. Annual report on the state of drug related problems in Bulgaria 2009. Sofia; 2010. https://reitox.emcdda.europa.eu/attachements.cfm/att_100155_EN_2009%20NATIONAL%20REPORT%20BG_en.pdf Accessed: 2010-05-18.
5National Drug Council. National Focal Point for Drugs and Drugs Addictions. Annual report on the drugs and drugs addictions problems in Bulgaria 2007. Sofia; December 2007. https://reitox.emcdda.europa.eu/attachements.cfm/att_49304_EN_AR%202007%20BG%20FIN_EN%20TO%20EMCDDA.doc Accessed: 2009-05-18.
6General Directorate of Implementation of Punishments.
7National focal point and General Directorate of Implementation of Punishments.
8Data from Ministry of Justice, Principal Office ‘Execution of punishments’, ‘Annual report on drug related problems in Bulgaria’ — 2005, National Drugs Council and national focal point, 2005.
9Data from Ministry of Justice, Principal Office ‘Execution of punishments’, Annual report on drug related problems in Bulgaria — 2005, National Drugs Council and national focal point, 2005.
Czech Republic1National monitoring centre for drugs and drug addiction & The Czech prison service (2011).
2Zábranský T, Radimecký J, Mravcík V, et al. Výrocní zpráva o stavu ve vecech drog pro Evropské monitorovací stredisko pro drogy a drogové závislosti [Report to the EMCDDA by the Reitox National Focal Point Czech Republic: Drug Situation 2001], National Focal Point Czech Republic & EMCDDA. Prague & Lisbon; 2002.
Denmark1Kramp P, Gabrielsen G, Lund A, Reventlow A, Sindballe A. Rusmiddelundersøgelsen-Misbrug blandt Kriminalforsorgens klientel. Copenhagen: Direktoratet for Kriminalforsorgen; 2003.
2National Board of Health, National Centre for Health Promotion and Prevention . Annual report on the drugs situation in Denmark 2002. National Board of Health, National Centre for Health Promotion and Prevention, Copenhagen; 2002. https://www.emcdda.europa.eu/attachements.cfm/att_34306_EN_NR2003Denmark.pdf Accessed: 02/05/2010.
Germany1Radun D, Weilandt C, Eckert J, et al. Presented at the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) 2007: Cross-sectional Study on Seroprevalence regarding Hepatitis B, Hepatitis C, and HIV, Risk Behaviour, Knowledge and Attitudes about Bloodborne Infections among adult Prisoners in Germany - Preliminary Results. Stockholm, October 2007.
2Tielking K, Becker S, Stöver H. Entwicklung gesundheitsfördernder Angebote im Justizvollzug, Oldenburg: Bibliotheks- und Informationssystem der Universität Oldenburg; 2003. http://docserver.bis.uni-oldenburg.de/__publikationen/bisverlag/2004/tieent03/pdf/tieent03.pdf. Accessed: 2010-05-18.
3Weilandt C. Rotily M. European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC. Marseille/Bonn, ORS/WIAD; 1998.
4Kern J. Zum Ausmaß des Drogenmißbrauchs in den Justizvollzugsanstalten und den Möglichkeiten seiner Eindämmung. Zeitschrift für Strafvollzug und Straffälligenhilfe. 1997; (2):90–92.
Greece1Sunora GC. Katagrafi apotelesmaton diereunisis kai protasi programmatos sti Dikastiki Fulaki Koridallou, Athina, Médecins Sans Frontières; 2001.
2Fotiadou M, Livaditis M, Manou I, Kaniotou E, Samakouri M, Tzavaras N, Xenitidis K. Self-reported substance misuse in Greek male prisoners. European Addiction Research. 2004; 10:56–60.
3Panepistimio A. Diereunisi anagon kai methodon epaggelmatikis katartisis anilikon paravaton kai anilikon se kindino ‘Orestis’ — Leonardo Da Vinci, Thessaloniki; 2000.
4Koulierakis G, Gnardelis C, Agrafiotis D, Power K. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addictions. 1995; (8):1207–1216.
5Malliori M, Sypsa V, Psichogiou M, Touloumi G, Skoutelis A., Tassopoulos N, Hanzakis A, Stefanis C. A survey of bloodborne viruses and associate risk behaviours in Greek prisons. Addiction. 1998; 93(2):243–245.
6Malliori M. European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC. Marseille/Bonn: ORS/WIAD.1998: pp. 114–118.
Spain1Delegación del Gobierno para el Plan Nacional sobre Drogas. Encuesta sobre salud y consumo de drogas a los internados en instituciones penitenciarias (ESDIP) 2006, Gobierno de España, Ministerio de Sanidad y Consumo, Ministerio del Interior. Madrid; 2006. http://www.pnsd.msc.es/Categoria2/publica/pdf/encuestaPenitenciaria2006.pdf. Accessed: 2010-05-18.
2Saiz de la Hoya P, Bedia M, Murcia J, Cebria J, Sanchez-Paya J, Portilla J. Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison. Enferm �nfecc Microbiol Clin 2005;23(2):53-57.
3Plan Nacional sobre el Sida y Dirección General de Instituciones Penitenciarias. Estudio sobre Drogodependientes que ingresan en prisión: Consumo y prácticas de riesgo. Plan Nacional sobre el Sida y Dirección General de Instituciones Penitenciarias. Ministerio del Interior. Madrid; 2000.
4Delegación del Gobierno para el Plan Nacional sobre Drogas y Dirección General de Instituciones Penitenciarias. Evolución terapéutica previa del drogodependiente que ingresa en 1994: Estudio transversal de junio de 1998 sobre sanidad penitenciaria. Dirección General de Instituciones Penitenciarias, Ministerio del Interior; Madrid 1998.
5Subdirección General de Sanidad Penitenciaria. Estudio Transversal sobre Sanidad Penitenciaria 22 junio 1998 Informe Interno. Ministerio del Interior, 1999
6Informe de la Comparecencia del Director General de Instituciones Penitenciarias en el Parlamento, Madrid; 1999.
7Miranda MJ, Barberet R, Canteras A, Romero E. Análisis de la eficacia y adecuación de la política penitenciaria a las necesidades y demandas de las mujeres presas. Barcelona: Mimeo; 1998
8Rios JC, Cabrera P. Mil voces Presas. Universidad Pontificia de Comillas, Madrid; 1998.
9Delegación del Gobierno para el Plan Nacional sobre Drogas y Dirección General de Instituciones Penitenciarias, Evolución Terapéutica previa del drogodependiente que ingresa en prisión, 1994.
France1Lukasiewicz M, Falissard B, Michel L, Neveu X, Reynaud M, Gasquet I. Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study. Subst Abuse Treat Prev Policy. 2007; (Jan)4; 2:1. http://www.idf.inserm.fr/download.asp?download=stockfile/u669/princart/e7.pdf Accessed: 2010-05-18.
2Sahajian F, Lamothe P, Fabry J. Psychoactive substance use among newly incarcerated prison inmates. Sante Publique. 2006 Jun;18(2):223-34.
3Mouquet M-C. La santé des personnes entrées en prison en 2003, Études et résultats n 386, Direction de la recherche, des études, de l'évaluation et de la statistique; Ministère de l'emploi, du travail et de la cohesion sociale, Ministère des solidarités, de la santé et de la famille; 2005. http://www.sante.gouv.fr/drees/etude-resultat/er-pdf/er386.pdf. Accessed: 2010-05-18.
4Mouquet M-C, Dumont M, Bonnevie M-C. La santé à l'entrée en prison: un cumul des facteurs de risque, Études et résultats nº4, Direction de la recherche, des études, de l'évaluation et de la statistique; ministère de l'emploi et de la solidarité, janvier 1999.
5Rotily M. Delorme C. L'usage de drogues en milieu carcéral, Drogues et toxicomanies: indicateurs et tendances, OFDT; 1999.
6Weilandt C. Rotily M. European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC. Marseille/Bonn, ORS/WIAD; 1998.
Ireland1Hannon F, Kelleher C, Friel S. General Healthcare Study of the Irish Prisoner Population, Dublin: Stationery Office; 2000.
2Long J, Allwright S, Barry J, Reaper-Reynolds S, Thornton L., Bradley F. Hepatitis B, Hepatitis C and HIV in Irish Prisoners, Part II: Prevalence and risk in committal prisoners, 1999, Government Publications, Dublin; 2000.
3Allwright S, Barry J, Bradley F, Long J, Thornton L.. Hepatitis B, hepatitis C and HIV in Irish prisoners: Prevalence and risk, Dublin, The Stationary Office; 1999. // Allwright S, Bradley F, Long J, Barry J, Thornton L., Parry J V. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey, British Medical Journal. 2000; 321:78-82.
4Mountjoy Prison Visiting Committee; 1997.
5O'Mahony P. Mountjoy Prisoners: A sociological and criminological profile, Department of Justice, Government Publications, Dublin; June 1997.
Italy1Presidency of the Council of Ministers. Annual Report on the state of prisons in Italy - 2011 y primer semestre 2012. in Annual Report to Parliament on the State of Drug Dependence in Italy - 2010. Ministry of Justice, Dept. of Prison Administration. Rome; 2012. http://www.politicheantidroga.it/media/569861/file%20cumulativo_light.pdf
2Presidency of the Council of Ministers. Annual Report on the state of prisons in Italy - 2009. in Annual Report to Parliament on the State of Drug Dependence in Italy - 2010. Ministry of Justice, Dept. of Prison Administration. Rome; 2010.
3Presidency of the Council of Ministers. Annual Report on the state of prisons in Italy - 2009. in Annual Report to Parliament on the State of Drug Dependence in Italy - 2009. Ministry of Justice, Dept. of Prison Administration. Rome; 2009.
4Presidency of the Council of Ministers. Annual Report on the state of prisons in Italy - 2008. in Annual Report to Parliament on the State of Drug Dependence in Italy - 2008. Ministry of Justice, Dept. of Prison Administration. Rome; 2009.
5Presidency of the Council of Ministers. Annual Report on the state of prisons in Italy - 2007. in Annual Report to Parliament on the State of Drug Dependence in Italy - 2007. Ministry of Justice, Dept. of Prison Administration. Rome; 2008.
6Presidency of the Council of Ministers. Annual Report on the state of prisons in Italy - 2006. in Annual Report to Parliament on the State of Drug Dependence in Italy - 2006. Ministry of Justice, Dept. of Prison Administration. Rome; 2007.
7Annual report to the Parliament on the state of drug dependence in Italy — 2005, Ministry of Welfare, Rome, 2006.
8Annual report to the Parliament on the state of drug dependence in Italy — 2004, DNPA, Rome, 2005.
9Relazione Annual al Parlamento sullo Stato delle Tossicodipendenze in Italia 2003, Ministero del Lavoro e delle Politiche Sociali, Rome, 2004.
10National survey on drug use and HIV infection amongst prison admissions in 2002, Ministry of Justice, Department for Prison Administration.
11National survey on drug use and HIV infection amongst prison admissions in 2001, Ministry of Justice, Department for Prison Administration.
12National survey on drug users and HIV+ among prisoners at 31.12.02, Ministry of Justice.
13National survey on drug users and HIV+ among prisoners at 31.12.01, Ministry of Justice.
14National survey on drug users and HIV+ among prisoners at 31.12.00, Ministry of Justice.
15National survey on drug users and HIV+ among prisoners at 31.12.99, Ministry of Justice.
16Rezza G, Scalia Tomba G, Martucci P, Massella M, Noto R, De Risio A, Brunetti B, Ardita S, Starnini G. Prevalence of the use of old and new drugs among new entrants in Italian prisons. Ann Ist Super Sanita. 2005;41(2):239-45.
17Babudieri et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy, Journal of Medical Virology. 2005; 76: 311-317.
18Weilandt C. Rotily M. European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC. Marseille/Bonn, ORS/WIAD; 1998.
Latvia1Snikere S. u.c. (2011) Narkotiku lietošanas izplatiba ieslodzijuma vietas Latvija. [Drug use prevalence in Latvia's prisons]. Riga: Veselibas ekonomikas centrs, Sociologisko petijumu instituts.
2Snikere, S, Trapencieris M, Vanaga S. Survey of prison inmates: Drug abuse prevalence in Latvia. Population survey report, Riga; 2003: 71-102.
Lithuania1Lithuanian Reitox National Focal Point (2011) 2012 National Report to the EMCDDA, Vilnius, Lithuania: Government of the Republic of Lithuania. Vilnius; 2012.
2REITOX National Focal Point for Drugs and Drug Addiction. 2005 National Report to the EMCDDA. Drug Control Department under the Government of the Republic of Lithuania. Vilnius; 2005. https://reitox.emcdda.europa.eu/attachements.cfm/att_13092_EN_Lithuania_National_report_to_the_EMCDDA_2005.pdf
3Narkauskaite L, Juozulynas A, Mackiewicz Z, Surkiene G, Prapiestis J. The prevalence of psychotropic substance use and its influencing factors in Lithuanian penitentiaries. Med Sci Monit. 2007; 13(3):CR131-135.
Luxembourg1Origer A, Removille R. Prévalence et propagation des hépatites A, B, C et du HIV au sein de la population des Usagers Problématiques de Drogues d'acquisition illicte au Luxembourg, PF/CES/CPR-Santé, Luxembourg; 2007.
2Schlink J, Etude épidémiologique des infections par le VIH et l'hépatite virale C dans les prisons luxembourgeoises. CPL, Luxembourg; 2000.
Hungary1Mészaros M. Fogvatartott drogfogyasztók főbb jellemzői (Main characteristics of imprisoned drug users). Budapest; 2009. (unpublished research report). http://www.szmm.gov.hu/download.php?ctag=download&docID=21764
2Paksi B. A jogerősen elítélt fogvatartottak kábítószer- és egyéb szenvedélyszer használata Magyarországon 2008-ban. Budapesti Corvinus Egyetem Magatartástudományi és Kommunikációelméleti Intézet Viselkedéskutató Központ. unpublished report. 2009.
3Elekes Zs.- Paksi B. Jogerősen elítélt fogvatartottak kábítószer- és egyéb szenvedélyszer használata. (unpublished research report), 2004.
4Elekes Zs, Paksi B. Exploration of risk groups of drug users in imprisoned population, IM.Bv.Op., Research Library for Penalty Authorities 1997/4 (112).
Malta1Ad-hoc file on 2011 admissions to Corradino Correctional Facility. 2012, from the Corradino Correctional Facility record files database.
2Ad-hoc file on 2010 admissions to Corradino Correctional Facility. 2011, from the Corradino Correctional Facility record files database.
3Ad-hoc file on 2009 admissions to Corradino Correctional Facility. 2010, from the Corradino Correctional Facility record files database.
4REITOX National Focal Point for Drugs and Drug Addiction. 2007 National Report on the Drug Situation in Malta. National Commission on the Abuse of Drugs, Alcohol and Other Dependencies. Ministry for the Family and Social Solidarity. Valletta; 2007. http://www.sedqa.gov.mt/pdf/information/reports_EMCDDA_2007.pdf. Accessed: 2010-05-18.
5Ad-hoc file on 2005 admissions to Corradino Correctional Facility. 2006, from the Corradino Correctional Facility record files database.
6Ad-hoc file on 2004 admissions to Corradino Correctional Facility. 2005, from the Corradino Correctional Facility record files database.
Netherlands1Goderie M. Problematiek en hulpvragen van stelselmatige daders. Utrecht: Verwey-Jonker Instituut; 2009.
2Bulten E, Nijman H. Veel psychiatrische stoornissen onder gedetineerden op regulier afdelingen van penitentiaire inrichtingen. Ned Tijdschr Geneesk. 2009; 153(A634):1-6.
3Oliemeulen L, Vuijk P, Rovers B, Van Den Eijnden R. Problematische alcoholgebruikers, druggebruikers en gokkers in het gevangeniswezen, Rotterdam, IVO/NJi/BTVO; 2007.
4Vogelvang BO, Van Burik A, Van der Knaap LM, Wartna, BSJ. Prevalentie van criminogene factoren bij mannelijke gedetineerden in Nederland, Den Haag, Adviesbureau Van Montfoort/WODC; 2003,
5Korf DJ, Benschop A, Rots G. Geweld, alcohol en drugs bij jeugdige gedetineerden en school drop-outs. Tijdschrift voor Criminologie. 2005;47(3): 239-54.
6De Vrught DFR. Psychisch gestoorden in detentie. Kenmerken van de groep psychisch gestoorde gedetineerden die bekend zijn bij de psycholoog in de inrichting.Dienst Justitiële Inrichtingen, Den Haag; 2000.
7Vreugdenhil C, Van Den Brink W, Wouters LF, Doreleijers TA. Substance use, substance use disorders, and comorbidity patterns in a representative sample of incarcerated male Dutch adolescents. J Nerv Ment Dis. 2003 Jun;191(6):372-8.
8Hildebrand M. Psychopathy in the treatment of forensic psychiatric patients. Assessment, prevalence, predictive validity, and clinical implications. University of Utrecht, Utrecht; 2004.
9Van Emmerik JL, Brouwers M. De Terbeschikkingstelling in Maat en Getal; Een beschrijving van de tbs-populatie in de periode 1995-2000, Den Haag: Ministerie van Justitie; 2001.
10Schoemaker C. Zessen G van. Psychische stoornissen bij gedetineerden; Een verkennend onderzoek in Penitentiair Complex Scheveningen. Utrecht, The Netherlands: Trimbos Institute; 1997.
11Koeter MWJ. Luhrman GC. Verslavingsproblematiek bij justitiabele drugverslaafden, Amsterdam: The Amsterdam Institute for Addiction Research (AIAR). Amsterdam; 1998.
12Bulten BH. Gevangen tussen straf en zorg [Caught between punishment and care]. (Doctoral thesis.), Amsterdam: Vrije Universiteit; 1998.
Austria1Country report Austria 1999 for the European network on HIV/AIDS and hepatitis in prisons, European centre for social welfare policy and research, Vienna; 1999.
2Pont J. Auswertung des Fragebogens zu GZ 52201/2-V.4/1996’, Bundesministerium für Justiz, 1996. In: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn, ORS/WIAD; 1998.
3‘Drogenfreie Zone im Strafvollzug’, unofficial report on one-year experience with the drug free zone in the Hirtenberg prison.
Poland1Sieroslawski J. Problem narkotykow i narkomanii w zakladach karnych i aresztach sledczych. Warszawa: Instytut Psychiatrii i Neurologii; 2007.
2Sieroslawski J. Projekt badan nad problemem narkomanii w zakladach karnych i aresztach sledczych. Raport za rok 2001. Warszawa: Instytut Psychiatrii i Neurologii; 2001.
Portugal1Torres A, Maciel D, Sousa, I, Cruz R. Drogas e prisões: Portugal 2001-2007. Lisboa, IDT; 2008.
2Torres A, Gomes M. Drogas e prisões em Portugal. Lisboa, IPDT; 2002.
3Weilandt C. Rotily M. European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC. Marseille/Bonn, ORS/WIAD; 1998.
Romania1Romanian Monitoring Centre for Drugs and Drug Addiction: Romanian National Report on Drug Situation, 2011. National Anti-Drug Agency, Bucharest; 2012.
Slovakia1REITOX National Focal Point in the Slovak Republic. 2005 National Report for the EMCDDA: The State of Drug Addiction and Drug Control in the Slovak Republic. The Government Office of the Slovak Republic. The General Secretariat of the Ministerial Board for Drug Addiction and Drug Control National Monitoring Centre for Drugs Bratislava; 2005. https://www.emcdda.europa.eu/attachements.cfm/att_34626_EN_NR2005Slovakia.pdf. Accessed: 2010-05-18.
Slovenia1Carli A, Kotnik A, Zdešar Vochl A, et al. Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2008. Ministrstvo za pravosodje, Ljubljana; 2009. http://www.google.co.uk/url?q=http://www.mp.gov.si/fileadmin/mp.gov.si/pageuploads/2005/PDF/uiks/LP_08_web.pdf&ei=PZPyS7DsLsb6_Abr58n_DA&sa=X&oi=unauthorizedredirect&ct=targetlink&ust=1274190405769449&usg=AFQjCNEUeRUFjpDZSG0_dGsRAo7olNV7nA . Accessed: 2010-05-18.
2Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2007. Ministrstvo za pravosodje, Ljubljana; 2008. http://www.google.co.uk/url?sa=t&source=web&ct=res&cd=3&ved=0CB0QFjAC&url=http%3A%2F%2Fwww.mp.gov.si%2Ffileadmin%2Fmp.gov.si%2Fpageuploads%2F2005%2FPDF%2Fuiks%2FLetno_porocilo_07_web.pdf&rct=j&q=Ministrstvo+za+Pravosodje+Republike+Slovenije%2C+Uprava+za+izvr%C5%A1evanje++kazenskih+sankcij+(2004).+Letno+poro%C4%8Dilo+2003.+Uprava+za+izvr%C5%A1evanje+kazenskih+sankcij.+Ljubljana.&ei=bnIDTJ3MKJOO_AaH_IjSCw&usg=AFQjCNHG_dgVb_XU7mnkcfEIiQvSd5qvOQ. Accessed: 2010-05-31.
3Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2006. Ministrstvo za pravosodje, Ljubljana; 2007. http://www.google.co.uk/url?sa=t&source=web&ct=res&cd=2&ved=0CBsQFjAB&url=http%3A%2F%2Fwww.mp.gov.si%2Ffileadmin%2Fmp.gov.si%2Fpageuploads%2F2005%2FPDF%2Fuiks%2FLP2006.pdf&rct=j&q=Ministrstvo+za+Pravosodje+Republike+Slovenije%2C+Uprava+za+izvr%C5%A1evanje++kazenskih+sankcij+(2004).+Letno+poro%C4%8Dilo+2003.+Uprava+za+izvr%C5%A1evanje+kazenskih+sankcij.+Ljubljana.&ei=bnIDTJ3MKJOO_AaH_IjSCw&usg=AFQjCNFi42X9nt3p1_sBZlLnM6CJPj5YSg. Accessed: 2010-05-31.
4Institute of Public Health of the Republic of Slovenia. Report on the Drug Situation in 2008 of the Republic of Slovenia. Institute of Public Health of the Republic of Slovenia, Ljubljana; 2009. https://www.emcdda.europa.eu/attachements.cfm/att_86770_EN_NR_2008_SI.pdf.. Accessed: 2010-05-18. // Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2005. Ministrstvo za pravosodje, Ljubljana; April 2006. http://www.mp.gov.si/fileadmin/mp.gov.si/pageuploads/2005/PDF/uiks/lp_2005_M_1A.pdf. Accessed: 2010-05-31.
5Ministrstvo za pravosodje, Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2004. Ljubljana; 2005. ISSN 1581-6338. Authors: Carli A, Hren M, Kotnik A, Magister N, Novak S, et al. http://www.mp.gov.si/fileadmin/mp.gov.si/pageuploads/2005/PDF/uiks/porocilo_uiks_2004.pdf. Accessed: 2010-05-31.
6Ministrstvo za pravosodje, Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2003. Ljubljana; April 2004. ISSN 1581-6338. http://www.mp.gov.si/fileadmin/mp.gov.si/pageuploads/2005/PDF/uiks/porocilo_uiks_2003.pdf. Accessed: 2010-05-31.
7Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2001. Ministrstvo za pravosodje, Ljubljana, 2002. http://www.mp.gov.si/fileadmin/mp.gov.si/pageuploads/2005/PDF/uiks/porocilo_uiks_2001_2.pdf. Accessed: 2010-05-31.
8Uprava za izvrševanje kazenskih sankcij: Letno porocilo 2000. Ministrstvo za pravosodje, Ljubljana, May 2001. http://www.mp.gov.si/fileadmin/mp.gov.si/pageuploads/2005/PDF/uiks/porocilo_uiks_2000.pdf. Accessed: 2010-05-31.
Finland1Joukamaa M and working group (2010). Rikosseuraamusasiakkaiden terveys, työkyky ja hoidontarve. [Health, working capacity and need for treatment of criminal sanctions clients.] Rikosseuraamuslaitoksen julkaisuja 1/2010. Vammala. Rikosseuraamuslaitos.
2STAKES and Ministry of Justice (Department of Prison Administration).
3Korte T, Pykäläinen J, Seppälä T. Drug abuse of Finnish male prisoners in 1995, Forensic Sci Int. 1998; Nov 97(2-3):171-83.
Sweden1Krantz L, Elmby J. Kriminalvårdsstyrelsen. Kriminalvårdens redovisning om drogsituationen. Kriminalvårdsstyrelsen, Norrköping; 2009. http://www.kriminalvarden.se/upload/statistik/krod/krod_2005_2006.PDF. Accessed: 2010-05-18.
2Weilandt C. Rotily M. European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC. Marseille/Bonn, ORS/WIAD; 1998.
United Kingdom1Plugge E, Yudkin P, Douglas N. Changes in women's use of illicit drugs following imprisonment. Addiction. 2009 Feb;104(2):215-22.
2Stewart D. Drug use and perceived treatment need among newly sentenced prisoners in England and Wales. Addiction. 2009 Feb;104(2):243-7.
3Singleton N, Pendry E, Simpson T. et al. The impact of mandatory drug testing in prisons. Home Office Online Report 03/05, Home Office, London; 2005. http://uk.sitestat.com/homeoffice/rds/s?rds.rdsolr0305pdf&ns_type=pdf&ns_url=%5Bhttp://www.homeoffice.gov.uk/rds/pdfs05/rdsolr0305.pdf%5D. Accessed: 2010-05-18.
4The Criminality Survey, Home Office. // Liriano, S., and Ramsay, M. 'Prisoners' drug use before prison and the links with crime', in Ramsay M. (Ed.) (2003) Prisoners' drug use and treatment: seven research studies, Home Office Research Study 267, Home Office, London; 2003.
5Weild AR, Gill ON, Bennett D, Livingstone SJM, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Communicable Disease and Public Health. June 2000; vol 3, NO 2.
6Singleton N, Meltzer H, Gatward R. Psychiatric morbidity among prisoners, ONS, Department of Health, London; 1997. // Singleton N, Farrel M, Meltzer H. Substance misuse among prisoners in England and Wales, London: ONS; 1999.
7Bellis MA, Weild AR, Beeching NJ, Mutton KJ, Syed Q. Prevalence of HIV and injecting drug use in men entering Liverpool prison. BMJ. 1997; 315:30-31 [taken from: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998].
8Prevalence of HIV in England and Wales in 1995, Annual report of the Unlinked Anonymous Seroprevalence Monitoring Programme in England and Wales, Department of Health, Public Health Laboratory Service, Institute of Child Health, London; 1996 [taken from: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn: ORS/WIAD; 1998].
9Bridgwood A, Malbon G. Survey of the physical health of prisoners. (taken from: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn, ORS/WIAD; 1998).
10Scottish Prison Service. 13th Prisoner Survey 2011. Scottish Prison Service, Edinburgh; 2012. http://www.sps.gov.uk/nmsruntime/saveasdialog.aspx?fileName=Prisoner%20Survey%20-%20Bulletin%2020113696_724.pdf
11Scottish Prison Service. 12th Prisoner Survey 2009, Executive summary. Scottish Prison Service, Edinburgh; 2009. http://www.sps.gov.uk/MultimediaGallery/e7698343-107e-48c9-90ce-80db7698b5b3.pdf. Accessed: 2010-05-18.
12Scottish Prison Service. 11th Prisoner Survey 2008, Executive summary. Scottish Prison Service, Edinburgh; 2008. http://www.sps.gov.uk//MultimediaGallery/e7698343-107e-48c9-90ce-80db7698b5b3.pdf. Accessed: 2010-09-27.
13Scottish Prison Service. 10th Prisoner Survey 2007, Executive summary. Scottish Prison Service, Edinburgh; 2007.
14Scottish Prison Service. 9th Prisoner Survey 2006, Executive summary. Scottish Prison Service, Edinburgh; 2006.
15Scottish Prison Service. 8th Prisoner Survey 2005, Executive summary. Scottish Prison Service, Edinburgh; 2005.
16Scottish Prison Service. 7th Prisoner Survey 2004, Executive summary. Scottish Prison Service, Edinburgh; 2004.
17Scottish Prison Service. 6th Prisoner Survey 2003, Executive summary. Scottish Prison Service, Edinburgh; 2003. http://www.sps.gov.uk/multimediagallery/378E0B02-C9D2-46A4-9711-D6F06698E000.pdf. Accessed: 2010-05-18
18Bird SM, Rotily M, Inside methodologies: for counting blood-borne viruses and injector-inmates' behavioural risks — results from European prisons. The Howard Journal. May 2002; Vol. 41, No 2.
19O'Mahony D, Fox C, Chapman T. Report of the survey of the female inmate population in Hydebank Wood Centre. Belfast; September 2005.
20O'Mahony D, Fox C, Chapman T. Report of the fifth survey of the male inmate population in Hydebank Wood Centre. Belfast; September 2005.
Croatia12011 National Report on the Drug Situation in Croatia. Office for Combating Narcotic Drugs Abuse of the Government of the Republic of Croatia. Zagreb, 2012
22011 National Report on the Drug Situation in Croatia. Office for Combating Narcotic Drugs Abuse of the Government of the Republic of Croatia. Zagreb, 2011
32010 National Report on the Drug Situation in Croatia. Office for Combating Narcotic Drugs Abuse of the Government of the Republic of Croatia. Zagreb, 2010.
4Vugrinec L, Bošnjak, A, Jerkovic, D. 2009 National Report on the Drug Situation in Croatia. Office for Combating Narcotic Drugs Abuse of the Government of the Republic of Croatia. Zagreb, October 2009.
Turkey1Öges K., Basabak A., Adult Survey and Evaluation Form Pilot Application Report (2011). General Directorate of Prisons and Detention Houses.
Norway1Friestad C. Skog Hansen L. Mental health problems among prison inmates: the effect of welfare deficiencies, drug use and self-efficacy', Journal of Scandinavian Studies in Criminology and Crime Prevention. 2005; Vol. 6:183-196.
2Odegard, E., ‘Men and women behind the right walls? Drug, alcohol and mental problems among Norwegian inmates’ (manuscript).
3Skardhamar T. Inmates' social background and living conditions', Journal of Scandinavian Studies in Criminology and Crime Prevention. 2003; Vol. 4:39-56.
4Stortingsmelding No 16 (1996–97) Narkotikapolitikken.
 

Page last updated: Friday, 26 April 2013